Inventor

CHENG XIAOLI

US8 patents

⚠️ This page may combine multiple inventors who share the name “CHENG XIAOLI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

PROTAGONIST THERAPEUTICS INC

7 patents

US9624268B2Apr 18, 2017

Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases

PROTAGONIST THERAPEUTICS INC40 citations97

US10941183B2Mar 9, 2021

Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases

PROTAGONIST THERAPEUTICS INC13 citations94

US10196424B2Feb 5, 2019

Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases

PROTAGONIST THERAPEUTICS INC26 citations93

US10035824B2Jul 31, 2018

Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases

PROTAGONIST THERAPEUTICS INC24 citations93

US10023614B2Jul 17, 2018

Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases

PROTAGONIST THERAPEUTICS INC23 citations93

US10787490B2Sep 29, 2020

Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases

PROTAGONIST THERAPEUTICS INC18 citations85

US11884748B2Jan 30, 2024

Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases

PROTAGONIST THERAPEUTICS INC0 citations62

JANSSEN PHARMACEUTICA NV

1 patent

US11939361B2Mar 26, 2024

Compositions of peptide inhibitors of Interleukin-23 receptor

JANSSEN PHARMACEUTICA NV2 citations63